About Viagra Labs and our editorial policy
How Viagra Labs selects products and sources, including Indian pharmacy listings and manufacturers, and separates information from medical advice.
Our purpose
Viagra Labs explains sexual health medicines and treatments with clear, source-based information. We connect ingredient guidance, product identities and treatment comparisons so you can understand the options and prepare useful questions for a clinician or pharmacist.
Product selection and sources
We use regulator records, product labels, Indian pharmacy databases and manufacturers’ own catalogues. For original brands we cite European, US, UK or Australian records; for Indian brands we cite Indian pharmacy listings such as Practo, Apollo Pharmacy and PharmEasy, or the manufacturer’s site; for ingredients developed in South Korea and Brazil we use published research, relevant company records and product leaflets where available. Profiles distinguish source retrieval dates from the current editorial review.
A record in one country does not prove authorization elsewhere, and an established manufacturer does not prove that every product with its name is registered where you live. Finding medicine records around the world explains the distinction and lists regulators in India, South Korea, Brazil and English-speaking countries.
The directory does not claim to contain every ED or PE product, certify a seller, authenticate a pack or guarantee current stock. Names with historical, supplier or incomplete identity evidence are presented separately as other product names, with their supported associations and remaining gaps stated.
Editorial and medical limits
“Sources checked” describes an editorial source check. It is not a claim of independent clinical review, and no clinical reviewer is represented on this site. The original publication date is retained where an imported article has been rewritten; its update date identifies the new revision.
Use the current leaflet supplied with the actual medicine and speak with a qualified clinician or pharmacist. Content here does not diagnose a condition or recommend an individual regimen.
Scope and commercial information
Our catalogue covers erectile dysfunction (ED) and premature ejaculation (PE), including original brands, Indian brands, single-ingredient dapoxetine and combination products. Fluoxetine and duloxetine are discussed in their off-label PE research and historical combination contexts, separately from licensed indications. We keep the two treatment purposes distinct. Female sexual health is outside the current product directory. Combination profiles identify all claimed ingredients and link to their separate guidance. Supplements are discussed as evidence and safety questions, not presented as approved ED medicines.
References to pharmacy databases support product identity; they are not recommendations to buy from those businesses. The catalogue does not rank or endorse sellers. Some articles also link to partner pharmacies so readers can see where a product is sold. Those are affiliate links: they appear under “Where to buy”, are marked as sponsored for search engines and are kept separate from the evidence.
How the catalogue grows
We add brands in batches after finding a primary record: a regulator entry, an Indian pharmacy listing that names the company, or the manufacturer’s own product page. When a listing exceeds the doses in reference labels, the profile says so rather than repeating it as guidance.